June 16, 2024
Nuclear Medicine & Radiopharmaceuticals Market to Witness Huge Growth by 2030 – Actinium Pharmaceuticals Inc., Alliance Medical, Avid Bioservices Inc
Nuclear Medicine or Radiopharmaceuticals Market Size Was Valued at USD 6.13 Billion in 2022, and is Projected to Reach USD 11.0 Billion by 2030, Growing at a CAGR of 7.6% From 2023-2030. Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is…
Ajitsharma